PMID- 18261897 OWN - NLM STAT- MEDLINE DCOM- 20080603 LR - 20161124 IS - 0960-0760 (Print) IS - 0960-0760 (Linking) VI - 109 IP - 1-2 DP - 2008 Mar TI - DHEA decreases HIF-1alpha accumulation under hypoxia in human pulmonary artery cells: potential role in the treatment of pulmonary arterial hypertension. PG - 81-9 LID - 10.1016/j.jsbmb.2007.12.001 [doi] AB - Previous work showed that dehydroepiandrosterone (DHEA) prevents and reverses chronic hypoxic pulmonary artery hypertension in rat via targeting smooth muscle cells. In our study, DHEA was tested on human pulmonary arterial smooth muscle cells (HPASMC) to identify its mechanism of action under hypoxia in vitro. We show that DHEA decreased HIF-1alpha accumulation under both "chemical hypoxia" with treatment by the iron chelator deferroxamin and gas hypoxia (1% O2). The mRNA levels of HIF-1alpha were unchanged whether or not DHEA was applied under chemical and gas hypoxia, as compared to controls in normoxia, suggesting a post-transcriptional effect of the steroid. Protein levels of prolyl hydroxylases responsible for HIF-1alpha degradation were not modified by DHEA treatment. In addition, a synthetic derivative of DHEA, 3beta-methyl-Delta5-androsten-17-one (which cannot be metabolized), was as active as DHEA on HIF-1alpha accumulation, as well as testosterone and 17beta-estradiol (E2). In HPASMC cultures under normoxia and both types of hypoxia, DHEA gave rise to Delta5-androstene-3beta,17beta-diol (ADIOL) and DHEA-sulfate (DHEA-S). Neither testosterone, nor E2 were found. In addition, ADIOL, DHEA-S, 7alpha-hydroxy-DHEA and Delta4-androstene-3,17-dione were ineffective on HIF-1alpha accumulation. The effect of DHEA per se reducing HIF-1alpha accumulation may be relevant to reduced hypoxia effects in pulmonary arterial hypertension. FAU - Dessouroux, A AU - Dessouroux A AD - INSERM U788 and Universite Paris-Sud, Faculte de medecine, UMR-S788, 80 rue du General Leclerc, F-94276, le Kremlin Bicetre, France. FAU - Akwa, Y AU - Akwa Y FAU - Baulieu, E E AU - Baulieu EE LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20071207 PL - England TA - J Steroid Biochem Mol Biol JT - The Journal of steroid biochemistry and molecular biology JID - 9015483 RN - 0 (Amino Acids, Dicarboxylic) RN - 0 (DNA Primers) RN - 0 (Enzyme Inhibitors) RN - 0 (HIF1A protein, human) RN - 0 (Hypoxia-Inducible Factor 1, alpha Subunit) RN - 0 (Iron Chelating Agents) RN - 3G0H8C9362 (Cobalt) RN - 3XMK78S47O (Testosterone) RN - 459AG36T1B (Dehydroepiandrosterone) RN - 4TI98Z838E (Estradiol) RN - EC 1.14.11.2 (Procollagen-Proline Dioxygenase) RN - EVS87XF13W (cobaltous chloride) RN - J06Y7MXW4D (Deferoxamine) RN - VVW38EB8YS (oxalylglycine) SB - IM MH - Amino Acids, Dicarboxylic/pharmacology MH - Base Sequence MH - Cells, Cultured MH - Cobalt/pharmacology MH - DNA Primers/genetics MH - Deferoxamine/pharmacology MH - Dehydroepiandrosterone/analogs & derivatives/metabolism/*pharmacology MH - Enzyme Inhibitors/pharmacology MH - Estradiol/pharmacology MH - Humans MH - Hypertension, Pulmonary/*drug therapy/etiology/genetics/*metabolism MH - Hypoxia/complications/*drug therapy/genetics/*metabolism MH - Hypoxia-Inducible Factor 1, alpha Subunit/genetics/*metabolism MH - Iron Chelating Agents/pharmacology MH - Models, Cardiovascular MH - Myocytes, Smooth Muscle/drug effects/metabolism MH - Procollagen-Proline Dioxygenase/antagonists & inhibitors/metabolism MH - Pulmonary Artery/cytology/*drug effects/*metabolism MH - Testosterone/pharmacology EDAT- 2008/02/12 09:00 MHDA- 2008/06/05 09:00 CRDT- 2008/02/12 09:00 PHST- 2008/02/12 09:00 [pubmed] PHST- 2008/06/05 09:00 [medline] PHST- 2008/02/12 09:00 [entrez] AID - S0960-0760(07)00273-7 [pii] AID - 10.1016/j.jsbmb.2007.12.001 [doi] PST - ppublish SO - J Steroid Biochem Mol Biol. 2008 Mar;109(1-2):81-9. doi: 10.1016/j.jsbmb.2007.12.001. Epub 2007 Dec 7.